恶病质：多方面治疗消耗性疾病。 - Suppr

Suppr

超能文献

Cachexia: Treat wasting illness on multiple fronts.

作者信息

Fearon Kenneth

机构信息

University of Edinburgh, UK.

出版信息

Nature. 2016 Jan 14;529(7585):156. doi: 10.1038/529156b.

DOI:10.1038/529156b

PMID:26762449

Abstract

摘要

相似文献

Cachexia: Treat wasting illness on multiple fronts.

Nature. 2016 Jan 14;529(7585):156. doi: 10.1038/529156b.

[Cachexia].

Duodecim. 2005;121(9):985-92.

Opportunities for targeting the fatigue-anorexia-cachexia symptom cluster.

Cancer J. 2014 Sep-Oct;20(5):325-9. doi: 10.1097/PPO.0000000000000065.

Evidence base for multimodal therapy in cachexia.

Curr Opin Support Palliat Care. 2012 Dec;6(4):424-31. doi: 10.1097/SPC.0b013e328359b668.

Cachexia.

Drugs Today (Barc). 2016 Sep;52(9):519-529. doi: 10.1358/dot.2016.52.9.2545017.

Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.

Nutr Cancer. 2015;67(1):12-26. doi: 10.1080/01635581.2015.976318. Epub 2014 Dec 16.

[Intensive therapy of protein-energy deficiency at the cachexia stage].

Anesteziol Reanimatol. 1986 Sep-Oct(5):14-7.

[Cachexia in chronic cardiac disease. Ancient syndrome new idea?].

Przegl Lek. 2006;63(3):151-4.

Treatment of unintentional weight loss in patients with cancer.

Nutr Clin Pract. 2005 Aug;20(4):400-10. doi: 10.1177/0115426505020004400.

Clinical results in cachexia therapeutics.

Curr Opin Clin Nutr Metab Care. 2016 May;19(3):199-204. doi: 10.1097/MCO.0000000000000274.

引用本文的文献

Wnt7a Counteracts Cancer Cachexia.

Mol Ther Oncolytics. 2020 Jan 11;16:134-146. doi: 10.1016/j.omto.2019.12.011. eCollection 2020 Mar 27.

Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Front Oncol. 2019 Dec 20;9:1409. doi: 10.3389/fonc.2019.01409. eCollection 2019.

Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.

Sci Rep. 2018 Dec 21;8(1):18024. doi: 10.1038/s41598-018-36626-3.

Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):987-1002. doi: 10.1002/jcsm.12354. Epub 2018 Oct 16.

Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.

Physiol Genomics. 2018 Dec 1;50(12):1071-1082. doi: 10.1152/physiolgenomics.00061.2018. Epub 2018 Oct 5.

Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.

J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):926-938. doi: 10.1002/jcsm.12232. Epub 2017 Aug 28.

Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.

Sci Rep. 2017 May 23;7(1):2273. doi: 10.1038/s41598-017-02347-2.

Practical multimodal care for cancer cachexia.

Curr Opin Support Palliat Care. 2016 Dec;10(4):298-305. doi: 10.1097/SPC.0000000000000241.

本文引用的文献

Request for regulatory guidance for cancer cachexia intervention trials.

J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):272-4. doi: 10.1002/jcsm.12083. Epub 2015 Nov 11.

Cachexia: The last illness.

Nature. 2015 Dec 10;528(7581):182-3. doi: 10.1038/528182a.

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cachexia: Treat wasting illness on multiple fronts.

Nature. 2016 Jan 14;529(7585):156. doi: 10.1038/529156b.

[Cachexia].

Duodecim. 2005;121(9):985-92.

Opportunities for targeting the fatigue-anorexia-cachexia symptom cluster.

Cancer J. 2014 Sep-Oct;20(5):325-9. doi: 10.1097/PPO.0000000000000065.

Evidence base for multimodal therapy in cachexia.

Curr Opin Support Palliat Care. 2012 Dec;6(4):424-31. doi: 10.1097/SPC.0b013e328359b668.

Cachexia.

Drugs Today (Barc). 2016 Sep;52(9):519-529. doi: 10.1358/dot.2016.52.9.2545017.

Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.

Nutr Cancer. 2015;67(1):12-26. doi: 10.1080/01635581.2015.976318. Epub 2014 Dec 16.

[Intensive therapy of protein-energy deficiency at the cachexia stage].

Anesteziol Reanimatol. 1986 Sep-Oct(5):14-7.

[Cachexia in chronic cardiac disease. Ancient syndrome new idea?].

Przegl Lek. 2006;63(3):151-4.

Treatment of unintentional weight loss in patients with cancer.

Nutr Clin Pract. 2005 Aug;20(4):400-10. doi: 10.1177/0115426505020004400.

Clinical results in cachexia therapeutics.

Curr Opin Clin Nutr Metab Care. 2016 May;19(3):199-204. doi: 10.1097/MCO.0000000000000274.

引用本文的文献

Wnt7a Counteracts Cancer Cachexia.

Mol Ther Oncolytics. 2020 Jan 11;16:134-146. doi: 10.1016/j.omto.2019.12.011. eCollection 2020 Mar 27.

Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Front Oncol. 2019 Dec 20;9:1409. doi: 10.3389/fonc.2019.01409. eCollection 2019.

Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.

Sci Rep. 2018 Dec 21;8(1):18024. doi: 10.1038/s41598-018-36626-3.

Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):987-1002. doi: 10.1002/jcsm.12354. Epub 2018 Oct 16.

Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.

Physiol Genomics. 2018 Dec 1;50(12):1071-1082. doi: 10.1152/physiolgenomics.00061.2018. Epub 2018 Oct 5.

Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.

J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):926-938. doi: 10.1002/jcsm.12232. Epub 2017 Aug 28.

Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.

Sci Rep. 2017 May 23;7(1):2273. doi: 10.1038/s41598-017-02347-2.

Practical multimodal care for cancer cachexia.

Curr Opin Support Palliat Care. 2016 Dec;10(4):298-305. doi: 10.1097/SPC.0000000000000241.

本文引用的文献

Request for regulatory guidance for cancer cachexia intervention trials.

J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):272-4. doi: 10.1002/jcsm.12083. Epub 2015 Nov 11.

Cachexia: The last illness.

Nature. 2015 Dec 10;528(7581):182-3. doi: 10.1038/528182a.

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST.